Test Price
100 AED✅ Home Collection Available
Hepatitis B e Antibody (Anti-HBe) Test in Dubai | 100 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Assurance & Standards: ISO 9001:2015 certified (Certificate INT/EGQ/2509DA/3139) with 99.9% diagnostic sensitivity validated for the detection of hepatitis B e antibodies using Chemiluminescent Immunoassay (CLIA) technology.
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM, or hospital-based draw at our Dubai Healthcare City laboratory.
Post-Test Guidance: Complimentary telephone interpretation of results with a qualified general practitioner.
Insurance & Billing: Real-time coverage verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Hepatitis B e Antibody (Anti-HBe) test is a qualitative serological assay that detects antibodies directed against the hepatitis B e antigen (HBeAg). This marker is essential for staging chronic hepatitis B virus (HBV) infection, monitoring seroconversion from the replicative phase to the inactive carrier state, and assessing response to antiviral therapy. A positive Anti-HBe result typically correlates with reduced viral replication and lower HBV DNA levels, whereas a negative result alongside detectable HBeAg indicates active viral proliferation and potential liver inflammation.
Our laboratory employs a fully automated CLIA platform known for its high signal-to-noise ratio, minimal cross-reactivity, and excellent reproducibility. Each assay run includes internal quality controls calibrated against international reference standards. Results are reported as reactive (positive) or non-reactive (negative) with a cutoff index value, and are always interpreted in the context of the complete HBV serological panel, including HBsAg, HBeAg, and anti-HBc.
| Feature | Anti-HBe CLIA (Our Service) | Rapid Anti-HBe Cassette |
|---|---|---|
| Methodology | Chemiluminescent Immunoassay (CLIA) | Lateral Flow Immunochromatography |
| Sensitivity (Clinical) | 99.9% (ISO-validated cutoff index) | ~85–92% (lot-dependent) |
| Specificity | 99.5% (verified against reference panel) | ~90–95% (variable) |
| Turnaround Time | Same day (daily scheduled runs) | 20–30 minutes (manual read) |
| Regulatory Oversight | DHA, MOHAP, ISO 9001:2015, UAE PDPL | Often unregulated or self-certified |
Physician Insight & Safety Protocols
Dr. Ajay Singh (General Practitioner, DHA Reg. ID: 36234132): “The Anti-HBe test provides critical information about the host immune response to HBV, but it must never be interpreted in isolation. I always counsel my patients to pair this result with HBeAg, HBV DNA quantification, and liver function tests before making any treatment decisions. A positive Anti-HBe alone does not guarantee inactive disease—especially in patients with elevated ALT or detectable viral load.”
Medication & Clinical Advisory
Important Precautions
- Do not discontinue prescribed antiviral therapy (e.g., entecavir, tenofovir) or immunosuppressive medications without explicit instruction from your hepatologist or infectious disease specialist.
- This test alone cannot distinguish between resolved infection and inactive carrier state; an undetectable HBV DNA level is required for confirmation.
- Patients with acute hepatitis symptoms—jaundice, dark urine, severe right-upper-quadrant pain, confusion, or bleeding—must seek emergency care immediately and should not rely on outpatient serology alone.
- Individuals receiving high-dose biotin therapy (>5 mg/day) may experience interference with CLIA-based results; inform your physician and laboratory prior to blood draw.
Exclusion Criteria & Emergency Red Flags
- Not indicated for the diagnosis of acute hepatitis B; serological confirmation requires IgM anti-HBc testing and clinical evaluation.
- Do not use this test as a standalone screening tool for blood donor qualification or occupational exposure management.
- Patients with known paraproteinemias, autoimmune hepatitis, or rheumatoid factor interference should discuss alternative assay platforms (e.g., ELISA with blocking steps) with their referring clinician.
Patient FAQ & Clinical Guidance
1. What is the purpose of the Hepatitis B e Antibody test?
This test detects antibodies produced by the immune system against the hepatitis B e antigen (HBeAg). A positive Anti-HBe result usually indicates seroconversion, meaning the virus has transitioned from a highly replicative state to a less active phase. It is used alongside HBeAg and HBV DNA to classify chronic HBV infection as either immune-active or inactive carrier state, and to monitor patients undergoing antiviral therapy.
2. Do I need to fast or prepare specially for this test?
No special preparation is required. A routine serum sample collected via venipuncture is sufficient. You may continue all prescribed medications unless your gastroenterologist or hepatologist advises otherwise. Fasting is not necessary, and the sample can be drawn at any time of day.
3. What does a positive Anti-HBe result mean for my liver health?
A positive Anti-HBe generally suggests that the immune system has gained control over the virus, leading to reduced HBV DNA levels and lower risk of liver inflammation. However, this interpretation depends on the full serological picture. Patients with detectable HBeAg and negative Anti-HBe typically have active viral replication and may require antiviral intervention. Always review your results with a qualified physician who can correlate them with your ALT levels, viral load, and liver imaging.
4. Can this test be performed during pregnancy?
Yes. The Anti-HBe test is routinely included in the HBV serological workup for pregnant women, especially those with known chronic HBV infection. It helps guide perinatal prophylaxis decisions. There are no contraindications to venipuncture during pregnancy, and the test poses no risk to the mother or fetus. Your obstetrician should coordinate the interpretation with a hepatology specialist if needed.
5. How long does it take to receive my Anti-HBe test result?
Results are typically available within 24 hours of sample collection. Our laboratory processes Anti-HBe assays on a daily schedule, and you will receive your report via email or WhatsApp as soon as the result is validated. A complimentary telephone consultation with our general practitioner is available to explain the findings and recommend follow-up steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework: This diagnostic service operates under DHA Facility License Number 1143 and adheres to the highest standards of patient data protection and clinical safety in the United Arab Emirates. Our laboratory follows the provisions of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all handling, storage, and transmission of your health information. Additionally, we comply with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields to ensure secure digital communication of test results. All clinical procedures are conducted in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing your rights to informed consent and safe medical practice. For any data privacy inquiries, contact our Data Protection Officer at support@dnalabsuae.com.
Clinical & Logistical Metadata
| Test Name | Hepatitis B e Antibody (Anti-HBe) |
| Price (AED) | 100 AED |
| Turnaround Time | Same day (results within 24 hours of sample collection) |
| Sample Type / Matrix | Peripheral venous serum (gold-top SST or plain tube) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) – fully automated platform |
| ICD-10-CM Code | B18.1 (Chronic hepatitis B without delta-agent), Z22.51 (Carrier of hepatitis B) |
| LOINC Code | 2965-2 (Hepatitis B e Ab [Presence] in Serum) |
| DHA Facility License & Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians